JP2015044878A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015044878A5 JP2015044878A5 JP2014248831A JP2014248831A JP2015044878A5 JP 2015044878 A5 JP2015044878 A5 JP 2015044878A5 JP 2014248831 A JP2014248831 A JP 2014248831A JP 2014248831 A JP2014248831 A JP 2014248831A JP 2015044878 A5 JP2015044878 A5 JP 2015044878A5
- Authority
- JP
- Japan
- Prior art keywords
- myxoma virus
- cancer cells
- pharmaceutical composition
- composition
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US80364006P | 2006-06-01 | 2006-06-01 | |
| US60/803,640 | 2006-06-01 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013040387A Division JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016197808A Division JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015044878A JP2015044878A (ja) | 2015-03-12 |
| JP2015044878A5 true JP2015044878A5 (enExample) | 2015-04-23 |
Family
ID=38802246
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Withdrawn JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2013040387A Expired - Fee Related JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2014248831A Pending JP2015044878A (ja) | 2006-06-01 | 2014-12-09 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009513472A Withdrawn JP2009538935A (ja) | 2006-06-01 | 2007-06-01 | 癌の処置のための粘液腫ウイルス変異体 |
| JP2013040387A Expired - Fee Related JP5665899B2 (ja) | 2006-06-01 | 2013-03-01 | 癌の処置のための粘液腫ウイルス変異体 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016197808A Pending JP2017008105A (ja) | 2006-06-01 | 2016-10-06 | 癌の処置のための粘液腫ウイルス変異体 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US8512713B2 (enExample) |
| EP (3) | EP3254694A1 (enExample) |
| JP (4) | JP2009538935A (enExample) |
| KR (1) | KR20090014364A (enExample) |
| CN (1) | CN101460194B (enExample) |
| AU (1) | AU2007256754B2 (enExample) |
| CA (2) | CA2951453A1 (enExample) |
| IL (1) | IL195297A (enExample) |
| MX (1) | MX2008015265A (enExample) |
| NZ (1) | NZ572893A (enExample) |
| WO (1) | WO2007143548A2 (enExample) |
| ZA (1) | ZA200809769B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512713B2 (en) | 2006-06-01 | 2013-08-20 | Robarts Research Institute | Myxoma virus mutants for cancer treatment |
| FR2946536B1 (fr) | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| US12128099B2 (en) | 2018-05-25 | 2024-10-29 | Bioventures, Llc | Myxoma virus compositions and methods of use |
| CA3112788A1 (en) | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| US12428626B2 (en) | 2018-11-20 | 2025-09-30 | Bioventures, Llc | Cells for the production of viruses and methods of using the same |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1905304A3 (en) | 1997-10-09 | 2008-08-13 | Wellstat Biologics Corporation | Treatment of neoplasms with viruses |
| ES2153284B1 (es) | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| CN1477964A (zh) | 1999-04-15 | 2004-02-25 | 应用病毒治疗肿瘤 | |
| AU6175000A (en) * | 1999-07-12 | 2001-01-30 | Viron Therapeutics, Inc. | Novel myxoma genes for immune modulation |
| WO2001087324A1 (en) | 2000-05-17 | 2001-11-22 | Viron Therapeutics, Inc. | Compositions and methods for promoting immunosuppression |
| BR0207761A (pt) * | 2001-03-08 | 2006-01-31 | Akzo Nobel Nv | Uso de um vìrus leporipox recombinante vivo, vacina, e, vìrus leporipox recombinante vivo |
| WO2004078206A1 (en) | 2003-03-07 | 2004-09-16 | Robarts Research Institute | Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| US20070207149A1 (en) | 2004-04-27 | 2007-09-06 | Wellstat Biologics Corporation | Cancer treatment using viruses and camptothecins |
| DK2388315T3 (da) * | 2005-03-07 | 2014-08-25 | Univ Western Ontario | Anvendelse af et myxomvirus, som ikke eksprimerer funktionelt M135R, til terapeutisk behandling |
| US8512713B2 (en) | 2006-06-01 | 2013-08-20 | Robarts Research Institute | Myxoma virus mutants for cancer treatment |
| WO2007143545A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
| WO2007147118A1 (en) | 2006-06-16 | 2007-12-21 | Robarts Research Institute | Infection of cells with myxoma virus requires akt activation |
-
2007
- 2007-06-01 US US12/301,961 patent/US8512713B2/en not_active Expired - Fee Related
- 2007-06-01 AU AU2007256754A patent/AU2007256754B2/en not_active Ceased
- 2007-06-01 CN CN2007800202887A patent/CN101460194B/zh not_active Expired - Fee Related
- 2007-06-01 NZ NZ572893A patent/NZ572893A/en not_active IP Right Cessation
- 2007-06-01 EP EP17182211.7A patent/EP3254694A1/en not_active Withdrawn
- 2007-06-01 EP EP11184754.7A patent/EP2457584B1/en not_active Not-in-force
- 2007-06-01 WO PCT/US2007/070219 patent/WO2007143548A2/en not_active Ceased
- 2007-06-01 JP JP2009513472A patent/JP2009538935A/ja not_active Withdrawn
- 2007-06-01 KR KR1020087029274A patent/KR20090014364A/ko not_active Ceased
- 2007-06-01 MX MX2008015265A patent/MX2008015265A/es active IP Right Grant
- 2007-06-01 CA CA2951453A patent/CA2951453A1/en not_active Abandoned
- 2007-06-01 CA CA2652228A patent/CA2652228C/en not_active Expired - Fee Related
- 2007-06-01 EP EP07798014A patent/EP2021023A4/en not_active Withdrawn
-
2008
- 2008-11-13 IL IL195297A patent/IL195297A/en active IP Right Grant
- 2008-11-13 ZA ZA200809769A patent/ZA200809769B/xx unknown
-
2013
- 2013-03-01 JP JP2013040387A patent/JP5665899B2/ja not_active Expired - Fee Related
- 2013-08-19 US US13/969,853 patent/US20130336930A1/en not_active Abandoned
-
2014
- 2014-12-09 JP JP2014248831A patent/JP2015044878A/ja active Pending
-
2016
- 2016-01-21 US US15/002,971 patent/US9980994B2/en active Active
- 2016-10-06 JP JP2016197808A patent/JP2017008105A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2024010140A (es) | Nuevos metodos. | |
| IL288104B1 (en) | Heterocyclic compounds, pharmaceutical preparations containing them and their use for the treatment of cancer | |
| MX2022006107A (es) | Metodos y composiciones para dosificacion en terapia celular adoptiva. | |
| EP3686200A3 (en) | Bicyclic heterocycle compounds and their uses in therapy | |
| JP2014141525A5 (enExample) | ||
| CL2014001792A1 (es) | Compuestos derivados de carbamato; composicion farmaceutica, y uso de los mismos en el tratamiento del dolor, cancer por tumor solido, obesidad, entre otras enfermedades. | |
| BR212016030926U2 (pt) | conjugados de alvo e partículas e formulações dos mesmos | |
| CA2956871C (en) | Compounds active towards bromodomains | |
| WO2015048689A8 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2016196776A3 (en) | Inhibitors of bruton's tyrosine kinase | |
| WO2015103438A3 (en) | Oncolytic virus adjunct therapy with agents that increase virus infectivity | |
| JP2016518337A5 (enExample) | ||
| CN111344398A (zh) | 分离的重组溶瘤腺病毒、药物组合物及其在治疗肿瘤和/或癌症的药物中的用途 | |
| JP2013155188A5 (enExample) | ||
| MY201105A (en) | Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus | |
| HUE060496T2 (hu) | Terápiás vegyületek és készítmények szociális zavarok és szerhasználati zavarok kezelésére | |
| PH12015502616A1 (en) | Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer | |
| WO2014164285A3 (en) | Use of levocetirizine and montelukast in the treatment of vasculitis | |
| EA201790563A1 (ru) | Применение реслизумаба для лечения эозинофильной астмы со степенью тяжести от умеренной до тяжелой | |
| WO2016048861A3 (en) | Heterocyclic compounds and use thereof | |
| ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
| SG11202103097QA (en) | Cancer therapy by combination use of oncolytic vaccinia virus and immune checkpoint inhibitor, and pharmaceutical composition and combination medicine for use in the cancer therapy | |
| PH12016502243A1 (en) | Pharmaceutical compositions for treating infectious diseases | |
| WO2015054678A3 (en) | Human papilloma virus therapeutic vaccine | |
| PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine |